CDK4 and cancer: Cancer is a malignant disease with a rapid‐growing mortality rate.[1] Aberrant cell proliferation caused by uncontrolled cell division is one of the key features of cancer.[2] Blocking cell division has been recognized as a potential therapeutic strategy.[3] Cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitors have recently attracted much attention from researchers.